2026 NPPES data Dermatology Physician NPI 1225062052 M.D.
Verify on CMS →

KAROL DANGARAN, M.D.

Dermatology Physician in ORANGE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
567
Medicare Part D claims · 251 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.2494/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$2.5K
106 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

KAROL DANGARAN, M.D. reported a CMS MIPS final score of 91.2494/100 — above the 83.1 national average — and filed 567 Medicare Part D claims in 2023.

91.2494/100
MIPS score · +8 vs avg
567
Part D claims, 2023
90%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KAROL DANGARAN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

KAROL DANGARAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about KAROL DANGARAN, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 07/10/2006

NPI 1225062052

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

567 22% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

91.2494/100 8.1494% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Dermatology Physician compares to other specialties among California providers

California providers

Dermatology Physician share within California

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within California

Medicare quality performance — MIPS

KAROL DANGARAN, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average

High performer (top quartile)
MIPS Final Score
91.2494/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 91.2494/100 vs national avg 83.1

0%100%National avg83%91.2%
MIPS final score (Dermatology Physician) — 91.2494/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KAROL DANGARAN, M.D. is a Dermatology Physician provider practicing in ORANGE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1225062052. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

KAROL DANGARAN, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 1506 E CHAPMAN AVE, ORANGE, CA, 92866, with a listed phone of (714) 538-8556. NPI 1225062052 was issued on 07/10/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DANGARAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 567 prescription claims written by this provider, covering 251 Medicare beneficiaries and totaling roughly $489K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.2494/100 for the 2023 performance year (Quality 82.4987), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1506 E CHAPMAN AVE
ORANGE, CA 92866

Provider Details

NPI 1225062052
Specialty Dermatology Physician
Credentials M.D.
Gender Female
NPI Issued 07/10/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.2494
Final Score
Avg: 83.1
82.4987
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KAROL DANGARAN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$2.5K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to KAROL DANGARAN, M.D.. To verify KAROL DANGARAN, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

KAROL DANGARAN, M.D. — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 567 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

567
Total Claims
$489K
Total Drug Cost
251
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
634
Total Day Supply
16,721
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$473K
Generic Drug Cost
$16K
Antibiotic Claims
86

Patient Demographics

Average Patient Age
76.0 years
Avg HCC Risk Score
1.34
Gender Split
67% female / 33% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Triamcinolone Acetonide
79
Doxycycline Hyclate
61
Fluocinonide
48
Clobetasol Propionate
43
Ciclopirox
Ciclopirox Olamine
26
Valacyclovir
Valacyclovir Hcl
26
Fluorouracil
23
Cosentyx Sensoready (2 Pens)
Secukinumab
20
Imiquimod
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How KAROL DANGARAN, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

KAROL DANGARAN, M.D.'s 567 claims are below the specialty average of 729.

Nearby Dermatology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as DANGARAN.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KAROL DANGARAN, M.D.'s specialty?
KAROL DANGARAN, M.D. specializes in Dermatology Physician and practices in ORANGE, California. Credentials: M.D..
How much does KAROL DANGARAN, M.D. prescribe under Medicare Part D?
In 2023, KAROL DANGARAN, M.D. wrote 567 Medicare Part D claims totaling $489K in drug costs for 251 beneficiaries.
What is KAROL DANGARAN, M.D.'s Medicare quality score?
KAROL DANGARAN, M.D. has a CMS MIPS Final Score of 91.2494/100 (Quality: 82.4987). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is KAROL DANGARAN, M.D. located?
KAROL DANGARAN, M.D. is located at 1506 E CHAPMAN AVE, ORANGE, CA, 92866. Phone: (714) 538-8556.
What is KAROL DANGARAN, M.D.'s NPI number?
KAROL DANGARAN, M.D.'s National Provider Identifier (NPI) is 1225062052, issued on 07/10/2006.
Does KAROL DANGARAN, M.D. prescribe more brand-name or generic drugs?
KAROL DANGARAN, M.D.'s prescribing is 10% brand-name and 90% generic drugs by claim count, with $473K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does KAROL DANGARAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, KAROL DANGARAN, M.D.'s most frequently prescribed drugs include Triamcinolone Acetonide, Doxycycline Hyclate, Fluocinonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KAROL DANGARAN, M.D. accept Medicare?
KAROL DANGARAN, M.D. appears in CMS Medicare data with 567 Part D claims and 251 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KAROL DANGARAN, M.D.'s credentials?
KAROL DANGARAN, M.D.'s NPI is 1225062052 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology